The 1:10 dilution of obtained cecal conditional media (CCM) was used to treat cells
The ClinicalTrials.gov registry shows multiple ongoing tirzepatide studies, but all focus on metabolic endpoints (weight loss, diabetes management, cardiovascular outcomes, obstructive sleep apnea) rather than autoimmune disease activity
1997 Mar;38(3):317-23
YangJLimSYKoYSLeeHYOhSWKimMGet al
10 Beyond economic endpoints, the model also showed clinically meaningful population health benefits, including reductions of 23.678 person-years per 100 patients of prediabetes and 25.963 person-years of T2D per 100 patient, along with additional reductions in several obesity-related comorbidities in the non-T2D population
GLP-1 slows gastric emptying, increases satiety, reduces appetite through central nervous system effects, and enhances glucose-dependent insulin secretion while suppressing glucagon release